Stada expands OTC business with portfolio of GSK drugs

Germany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products from GlaxoSmithKline.

GSK teams up with Clover on coronavirus vaccine

GSK begins cancer cell therapy tie-up with Immatics

Cancer biotech Immatics has begun a collaboration with GlaxoSmithKline to develop novel therapies built around its T-cell-based technology.

GW Pharma tops list of UK R&D spenders

Pharma is leading the way in R&D investment in the UK, with cannabis medicine specialist GW splurging almost 1,345% of its total revenue on research according to an analysis.

GSK sets out plans to split following full year earnings mis...

GlaxoSmithKline has set out a two-year plan to split itself in two after missing its earnings targets in full year results and predicting a decline in earnings this year.

GSK donates booster technology to coronavirus vaccine effort

GlaxoSmithKline has joined with the not-for-profit organisation the Coalition for Epidemic Preparedness Innovations (CEPI) to supply a booster for a potential Wuhan coronavirus vaccine.